A Study in Participants With Psoriatic Arthritis Attending Dermatology Clinics
NCT02470481 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 250
Last updated 2016-09-02
Summary
The purpose of this study is to conduct full psychometric testing of the Early Arthritis for Psoriatic Patients (EARP) questionnaire in Australian, Korean and Chinese populations
Conditions
Interventions
- OTHER
-
No Intervention
This is an obervational study
Sponsors & Collaborators
-
Janssen Research & Development, LLC
lead INDUSTRY
Principal Investigators
-
Janssen Research & Development, LLC Clinical Trial · Janssen Research & Development, LLC
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-03-31
- Primary Completion
- 2016-07-31
- Completion
- 2016-07-31
Countries
- Australia
- China
- South Korea
Study Locations
More Related Trials
-
Observational Study of Patients With Moderate to Severe Chronic Plaque Psoriasis
NCT03982394 ·Status: COMPLETED
-
Therapeutic Drug Monitoring of Risankizumab in Psoriasis Patients (BIOLOPTIM-RIS)
NCT05685940 ·Status: RECRUITING ·Phase: PHASE4
-
A Study Comparing Risankizumab to Placebo in Participants With Active Psoriatic Arthritis Including Those Who Have a History of Inadequate Response or Intolerance to Biologic Therapy(Ies)
NCT03671148 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Study of Psoriatic Arthritis
NCT00001420 ·Status: COMPLETED
-
A Study to Assess How Well Certolizumab Pegol Works in Patients With Moderate to Severe Plaque Psoriasis as Part of Routine Clinical Practice
NCT04053881 ·Status: COMPLETED
-
Modifying PEST for Psoriatic Arthritis Screening
NCT06382051 ·Status: RECRUITING ·Phase: NA
-
A Study to Determine the Efficacy and Safety of Deucravacitinib Compared With Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Are Naïve to Biologic Disease Modifying Anti-rheumatic Drugs or Had Previously Received TNFα Inhibitor Treatment
NCT04908189 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Study of the Clinical Activity, Safety, and Tolerability of SRT2104 in Subjects With Moderate to Severe Plaque-Type Psoriasis
NCT01154101 ·Status: COMPLETED ·Phase: PHASE2
-
Real-World Effectiveness of Dupilumab in Patients With Prurigo Nodularis: An Observational Study
NCT05991323 ·Status: ACTIVE_NOT_RECRUITING
-
A Phase II Study to Evaluate the Efficacy and Safety of D-2570 in Subjects With Active Psoriatic Arthritis
NCT07315061 ·Status: RECRUITING ·Phase: PHASE2
-
A Study Comparing Risankizumab to Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Have a History of Inadequate Response to or Intolerance to at Least One Disease Modifying Anti-Rheumatic Drug (DMARD) Therapy
NCT03675308 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
A Study to Assess Efficacy and Safety of Two Different Dose Regimens of Risankizumab Administered Subcutaneously in Japanese Subjects With Generalized Pustular Psoriasis or Erythrodermic Psoriasis
NCT03022045 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy Study of Apremilast to Treat Psoriatic Arthritis
NCT01925768 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Efficacy and Safety of PF-06700841 in Subjects With Active Psoriatic Arthritis
NCT03963401 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical and Molecular Characterization of Axial Psoriatic Arthritis (PsA), A Pilot Study
NCT05925842 ·Status: UNKNOWN
-
Study to Evaluate Psoriasis Severity and Its Psychosocial Impact Using the Simplified Psoriasis Index (SPI), as Well as Long-term Safety, Tolerability and Efficacy of Secukinumab Administered Subcutaneously in Patients With Moderate to Severe Psoriasis
NCT02595970 ·Status: COMPLETED ·Phase: PHASE3
-
Cytokine Expression in Psoriasis Patients with and Without Joint Involvement
NCT05307809 ·Status: RECRUITING ·Phase: NA
-
Exploration of the Cellular and Molecular Mechanisms in Patients Receiving Biotherapies Targeting the IL-23/IL-17 Axis in Cutaneous Psoriasis
NCT05111210 ·Status: RECRUITING
-
ACT-128800 in Psoriasis
NCT00852670 ·Status: COMPLETED ·Phase: PHASE2
-
Phase II Study of Apremilast (CC-10004) in Adults With in Psoriatic Arthritis
NCT00456092 ·Status: COMPLETED ·Phase: PHASE2
-
Real World Study on the Efficacy and Safety of Apremilast in Chinese Patients With Moderate to Severe Plaque Psoriasis, a Multi Center, Prospective, Observational Trial（REACT）
NCT05863273 ·Status: COMPLETED
-
An Observational Study to Evaluate Patient-Reported Experiences of Living With Moderate-to-Severe Plaque Psoriasis
NCT01555606 ·Status: COMPLETED
-
A Study to Evaluate Efficacy and Safety of HS-10374 for Moderate to Severe Plaque Psoriasis
NCT06077331 ·Status: RECRUITING ·Phase: PHASE2
-
Combining Acitretin and Efalizumab in the Therapy of Chronic Plaque Psoriasis
NCT00707070 ·Status: UNKNOWN ·Phase: PHASE4
-
A Real-world Study to Evaluate the Effectiveness of Deucravacitinib in Adults With Plaque Psoriasis in France (RePhlect)
NCT06701513 ·Status: RECRUITING